| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,239 |
13,545 |
$597K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,207 |
4,193 |
$335K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,984 |
3,962 |
$308K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25,310 |
8,135 |
$277K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,699 |
2,693 |
$229K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,396 |
3,110 |
$166K |
| 99429 |
|
3,755 |
3,737 |
$127K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,227 |
1,226 |
$114K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,242 |
3,404 |
$100K |
| 92552 |
|
4,059 |
4,048 |
$70K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,087 |
9,060 |
$59K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,291 |
4,072 |
$59K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,006 |
952 |
$40K |
| 90677 |
|
852 |
852 |
$37K |
| 99381 |
|
403 |
401 |
$33K |
| 90461 |
|
6,529 |
5,579 |
$30K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
974 |
898 |
$12K |
| 99383 |
|
82 |
82 |
$8K |
| 99382 |
|
54 |
54 |
$5K |
| 92551 |
|
1,602 |
1,600 |
$4K |
| 87807 |
|
229 |
219 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
38 |
38 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
259 |
258 |
$2K |
| 96160 |
|
1,447 |
1,446 |
$1K |
| 81002 |
|
217 |
208 |
$619.04 |
| 99000 |
|
55 |
54 |
$561.60 |
| 90734 |
|
135 |
134 |
$144.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
169 |
165 |
$103.31 |
| 90651 |
|
282 |
281 |
$0.00 |
| 90744 |
|
1,702 |
1,697 |
$0.00 |
| 90680 |
|
2,349 |
2,338 |
$0.00 |
| 90716 |
|
486 |
485 |
$0.00 |
| 90698 |
|
441 |
437 |
$0.00 |
| 90686 |
|
345 |
345 |
$0.00 |
| 90619 |
|
72 |
71 |
$0.00 |
| 90700 |
|
3,462 |
3,447 |
$0.00 |
| 90707 |
|
483 |
482 |
$0.00 |
| 90713 |
|
2,544 |
2,533 |
$0.00 |
| 90670 |
|
2,650 |
2,633 |
$0.00 |
| 99173 |
|
5,664 |
5,650 |
$0.00 |
| 90715 |
|
117 |
116 |
$0.00 |
| 90648 |
|
2,652 |
2,639 |
$0.00 |
| 90710 |
|
397 |
396 |
$0.00 |
| 90685 |
|
416 |
415 |
$0.00 |
| 90672 |
|
110 |
108 |
$0.00 |
| 90633 |
|
1,613 |
1,608 |
$0.00 |